Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.
Saved in:
| Title: | Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022. |
|---|---|
| Authors: | O'Laughlin K, Tobolowsky FA, Elmor R, Overton R, O'Connor SM, Damon IK, Petersen BW, Rao AK, Chatham-Stephens K, Yu P, Yu Y |
| Corporate Authors: | CDC Monkeypox Tecovirimat Data Abstraction Team |
| Source: | MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Sep 16; Vol. 71 (37), pp. 1190-1195. Date of Electronic Publication: 2022 Sep 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
